Some atopic diseases affect asthma outcomes more than others, said Basil Kahwash, MD, an assistant professor of medicine on the clinical educator track in the Department of Medicine at Vanderbilt University Medical Center, who spoke at CHEST 2022.
Some atopic diseases affect asthma outcomes more than others, according to Basil Kahwash, MD, an assistant professor of medicine on the clinical educator track in the Department of Medicine at Vanderbilt University Medical Center.
Transcript
Is it possible to pick one comorbidity that has the greatest impact on asthma outcomes?
Certainly possible—it's not easy, because they're all pretty impactful when it comes to asthma outcomes. But I would say, if I had to pick one that makes the largest impact, at least at the population level, it's going to be allergic rhinitis, even though we often think of allergic rhinitis, as a pretty simple disease, pretty simple comorbidity. A lot of people have it. It's just a runny nose at the end of the day. As a contributor to asthma outcomes, it's so widespread and so common that I would say that not enough people are controlling their allergic rhinitis, if they have comorbid asthma. And really, if we can accomplish that at a population level, that's where you're going to see the biggest impact on asthma outcomes. It coexists with so many cases of asthma, that if you're treating allergic rhinitis well, and really reinforcing to asthma patients that they need to be treating their allergic rhinitis, among all of the millions of people who have both asthma and allergic rhinitis, you're going to see better outcomes.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More